Portola Pharmaceuticals To Present New Analysis From ANNEXA-4 Study Of Its Factor Xa Inhibitor Reversal Agent Andexxa In Patients With Acute Gastrointestinal Bleeding At American College Of Gastroenterology Oct. 29